Skip to content

Public FDA record

Z-1130-2026: Brand Name: LEASEIR Product Name: LEASEIR MHR XCELL Model/Catalog Number: MHR 110-b Software Version: 1.5

Recall record Z-1130-2026 for LEASEIR TECHNOLOGIES SLU. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1130-2026
Company in FDA record
LEASEIR TECHNOLOGIES SLU
FDA classification date
Jan 16, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The console label for affected devices is missing the "DANGER" symbol.

Source facts

Action
On October 29, 2025, the firm notified the single US consignee. This was followed up by an email on December 18, 2025. The consignee was given information regarding the field corrective action for the console labels and missing danger symbol. The consignee was provided with replacement labels and instructions for the correction of both affected units.
Initiated
2025-12-15
Root cause
Error in labeling
Distribution
US Nationwide distribution in the states of Austin, Texas.
Recall number
Z-1130-2026
Recall status
Completed
CDRH record ID
217791
FDA classified
2026-01-16
Recall event number
98176

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗